Bionano Genomics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 9.32 million compared to USD 7.22 million a year ago. Net loss was USD 112.57 million compared to USD 31.81 million a year ago. Basic loss per share from continuing operations was USD 3.22 compared to USD 1.1 a year ago.
For the nine months, revenue was USD 25.4 million compared to USD 19.59 million a year ago. Net loss was USD 188.6 million compared to USD 93.92 million a year ago. Basic loss per share from continuing operations was USD 5.85 compared to USD 3.28 a year ago.